Dialogue Health Technologies Inc.

DLHTFOTCHealthcare

$3.79

+$0.02(+0.59%)

Market Cap$254797554

P/E Ratio—

52W High$3.7922

52W Low$2.07

Avg Volume8

Open$3.79

Beta2.66

Free Cash Flow Financials Revenue

Dialogue Health Technologies Inc. (DLHTF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

DLHTF · free cash flow · updated Jun 9, 2026

Core FCF metrics

DLHTF · FCF · TTM · margin & CAGR

Free cash flow was −$16.0M for FY2022 (fiscal year ending 2022-12-31), up 33.3% year-over-year The FCF margin was -18.4%.

FY2022 Free Cash Flow−$16.0M▲ +33.3% YoY

Trailing 12M (TTM)−$6.6Mtrailing 4 quarters sum

FCF Margin-18.4%−$16.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

DLHTF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$15.6M(0M)−$16.0M▲ +33.3%-18.4%

FY2021−$23.3M(1M)−$24.0M▼ 24.1%-35.3%

FY2020−$18.4M(1M)−$19.4M▼ 42.4%-54.1%

FY2019−$13.0M(1M)−$13.6M▼ 29.5%-134.7%

FY2018−$9.7M(1M)−$10.5M—-261.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

DLHTF · P/FCF · FCF yield · FCF per share

Dialogue Health Technologies Inc. (DLHTF) reported negative free cash flow of −$0.02B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

DLHTF · cash flow statement · operating / investing / financing

For FY2022, Dialogue Health Technologies Inc. generated −$15.6M in operating cash flow and spent 0M in capital expenditures, yielding −$16.0M in free cash flow.

Operating Activities

−$15.6M

Cash from core business operations

2022-12-31

Investing Activities

−$24.7M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

−$1.2M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$15.6M) − |CapEx| (0M) = FCF (−$16.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

DLHTF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Dialogue Health Technologies Inc.YOU

DLHTF

−$16.0M+33.3%-18.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Dialogue Health Technologies Inc. (DLHTF) reported free cash flow of −$16.0M for FY2022 (fiscal year ending 2022-12-31), up 33.3% year-over-year. The FCF margin was -18.4%.

Dialogue Health Technologies Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 5 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

DLHTF free cash flow · 8 questions

Dialogue Health Technologies Inc. free cash flow was −$16.0M for FY2022, up 33.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$6.6M.

DLHTF free cash flowDLHTF FCFDLHTF FCF 2022DLHTF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Dialogue Health Technologies Inc. · Dialogue Health Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026